» Articles » PMID: 25728774

A Somatic MAP3K3 Mutation is Associated with Verrucous Venous Malformation

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2015 Mar 3
PMID 25728774
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Verrucous venous malformation (VVM), also called "verrucous hemangioma," is a non-hereditary, congenital, vascular anomaly comprised of aberrant clusters of malformed dermal venule-like channels underlying hyperkeratotic skin. We tested the hypothesis that VVM lesions arise as a consequence of a somatic mutation. We performed whole-exome sequencing (WES) on VVM tissue from six unrelated individuals and looked for somatic mutations affecting the same gene in specimens from multiple persons. We observed mosaicism for a missense mutation (NM_002401.3, c.1323C>G; NP_002392, p.Iso441Met) in mitogen-activated protein kinase kinase kinase 3 (MAP3K3) in three of six individuals. We confirmed the presence of this mutation via droplet digital PCR (ddPCR) in the three subjects and found the mutation in three additional specimens from another four participants. Mutant allele frequencies ranged from 6% to 19% in affected tissue. We did not observe this mutant allele in unaffected tissue or in affected tissue from individuals with other types of vascular anomalies. Studies using global and conditional Map3k3 knockout mice have previously implicated MAP3K3 in vascular development. MAP3K3 dysfunction probably causes VVM in humans.

Citing Articles

30 years' experience in the use of cutaneous lasers for the treatment of verrucous venous malformations in children: a retrospective cohort study at Great Ormond Street Hospital for children.

Azad A, Schweighart Gate E, Rinaldi G, Alenezi H, Syed S Lasers Med Sci. 2025; 40(1):60.

PMID: 39894904 DOI: 10.1007/s10103-025-04326-w.


Cerebral vascular malformations: pathogenesis and therapy.

He Q, Huo R, Sun Y, Zheng Z, Xu H, Zhao S MedComm (2020). 2024; 5(12):e70027.

PMID: 39654683 PMC: 11625509. DOI: 10.1002/mco2.70027.


Congenital Vascular and Lymphatic Diseases.

Jung R, Trivedi C Circ Res. 2024; 135(1):159-173.

PMID: 38900856 PMC: 11192239. DOI: 10.1161/CIRCRESAHA.124.323181.


Vascular Malformations.

Bhari N, Agarwal A, Asritha C, Panda M, Mahajan R Indian Dermatol Online J. 2024; 15(3):415-430.

PMID: 38845674 PMC: 11152494. DOI: 10.4103/idoj.idoj_633_23.


Updates in Genetic Testing for Head and Neck Vascular Anomalies.

Woodis K, Garlisi Torales L, Wolf A, Britt A, Sheppard S Oral Maxillofac Surg Clin North Am. 2023; 36(1):1-17.

PMID: 37867039 PMC: 11092895. DOI: 10.1016/j.coms.2023.09.001.


References
1.
Kurek K, Luks V, Ayturk U, Alomari A, Fishman S, Spencer S . Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet. 2012; 90(6):1108-15. PMC: 3370283. DOI: 10.1016/j.ajhg.2012.05.006. View

2.
Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

3.
Yang J, Boerm M, McCarty M, Bucana C, Fidler I, Zhuang Y . Mekk3 is essential for early embryonic cardiovascular development. Nat Genet. 2000; 24(3):309-13. DOI: 10.1038/73550. View

4.
Deng Y, Yang J, McCarty M, Su B . MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis. Am J Physiol Cell Physiol. 2007; 293(4):C1404-11. DOI: 10.1152/ajpcell.00058.2007. View

5.
Wang L, Gao T, Wang G . Verrucous hemangioma: a clinicopathological and immunohistochemical analysis of 74 cases. J Cutan Pathol. 2014; 41(11):823-30. DOI: 10.1111/cup.12385. View